Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02331316
Other study ID # ThinkWell PLOT-02
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2019
Est. completion date November 2019

Study information

Verified date March 2021
Source ThinkWell
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to find out if drinking extra water helps people lose or maintain weight loss and reduce hunger and, if so, what volume of water is most effective and when is it best to drink it.


Description:

Obesity is a major public health problem. Observational data suggest that drinking water is associated with a healthier weight. Indeed advice to drink extra water to help with weight control is widespread (eight 8oz glasses or 2L of water a day is a common recommendation). The public spends billions of dollars on bottled water in the belief that it works and people are increasingly carrying water with them throughout the day. However, a systematic review of randomized controlled trials looking at the effectiveness of drinking extra water to help reduce weight or weight gain or produce changes in surrogate markers such as appetite or caloric intake undertaken by our group showed that currently there is an absence of reliable evidence to support the recommendation to drink water. It is important to establish whether drinking extra water is indeed helpful for weight control and, if so, what is the optimal quantity to recommend, as this could have an important impact of public health and public health policies if it is indeed effective. Tap water is so readily available in this country that even if the improvement in weight maintenance or reduction is small, this will be a cost-effective intervention. If it is not effective, then it is important that people know this so that they can make an informed choice about buying bottles of water for their health. The primary clinical question the study will address is does drinking extra water prevent or reduce weight gain? The secondary clinical questions it will ask are: 1. Does drinking water reduce hunger or increase satiety 2. Does drinking water increase participants' sense of well-being 3. What is the effect of the different volumes of water on nocturnal urination patterns? Once participants decide to take part in this trial, they will be asked to drink a specific amount of water at particular times of the day for 6 months. A computer will decide by chance the amount of water they will be asked to drink each day of the trial and the times at which to drink this. There are different amounts and different times that people will be asked to drink water, this is so that investigators can find out if there is an optimal volume of water to drink, and a best time to drink water to reduce headaches or hunger. The least amount of water the computer could ask participants to drink is half a glass (that is 4oz or 120ml). The largest volume of water the computer could ask a participant to drink would be eight glasses of water a day (a total of 64oz or 2L) spread across the day (that is not all at once). Once the computer has assigned participants to a particular volume and times to drink water, these will remain the same for every day throughout the study. Participant will be asked to provide some brief information about themselves at the beginning of the study (for example, age, sex, height and whether they exercise, smoke or not). During the study they will be asked to weigh themselves and record this, their dietary habits and the amount they drink will be stored on a private and confidential page on the study website. They will be asked to fill in [2] confidential short surveys about how they feel and their views, one at the start and one at the end of the study


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 2019
Est. primary completion date August 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Any adult (defined as someone aged 18 or above) for who advice to drink extra water is not contraindicated. Exclusion Criteria: General: 1. < 18 years of age 2. No personal email address 3. Pregnancy 4. Ecstasy recreational drug use Health conditions: 1. Impaired renal function 2. Chronic bowel problems 3. Low sodium levels 4. Diabetes insipidus 5. Schizophrenia or history of psychosis 6. Congestive heart failure 7. Current chemotherapy treatment 8. Anorexia 9. bulimia Concurrent Medications: 1. Taking regular non-steroidal anti-inflammatory drugs 2. Diuretics (e.g. thiazides, indapamide, loop diuretics), also called "water tablets" 3. Anti-depressants Selective serotonin re-uptake inhibitors (SSRIs), Tricyclic and tetracyclic antidepressants (TCAs),monoamine oxidase inhibitor (MAOIs) 4. Anti-psychotics (e.g. haloperidol) 5. Anti-convulsants (e.g. sodium valproate, carbamazepine) Implicit exclusions: 1. People without internet access 2. People who cannot read 3 People without the ability to understand the website and informed consent documents

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Daily extra water intake
Intervention-A: Timing of assigned daily extra water intake specified Intervention-B: Daily extra water assigned at any time during 24 hour period

Locations

Country Name City State
United Kingdom ThinkWell and City University London Oxford Oxfordshire

Sponsors (1)

Lead Sponsor Collaborator
ThinkWell

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

1 Price A, Burls A, Spurden D, et al. Water intake for weight reduction: a Systematic Review. PROSPERO. 2013.http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013004998

1 Price A, Burls A. PLOT-IT Public Led Online Trials Infrastructure and Tools. In: Force 2015. Oxford UK: : Force2015 2015. doi:DOI: 10.13140/2.1.1992.6082

Outcome

Type Measure Description Time frame Safety issue
Primary Weight loss or maintenance recorded online using participant reported outcome measures(PROMS) Weight loss or maintenance recorded online using participant reported outcome measures(PROMS). Participants will be asked to record weight using a supplied body mass index calculator and home weight scales weekly or as a minimum at baseline and close of study 6 months
Secondary Hunger intensity and satiety recorded online using participant reported outcome measures(PROMS) Hunger intensity and satiety recorded online using participant reported outcome measures(PROMS). Participants will be asked to self report hunger and satiety levels using a mobile app, web or journal using a visual analog scale (VAS ) on a daily basis or as a minimum at baseline and close of study 6 months
Secondary Well-being as measured by The PROMIS Well-being measure The PROMIS Well-being measure will be administered to participants monthly,
There will be a VAS Mood scale where they can record sad to happy mood at the same time they record hunger
6 months
Secondary Nightly micturition frequency as measured by self report Participants will self report weekly if nightly micturition frequency increases, decreases or there is no change 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2